Detalhe da pesquisa
1.
Frequency of hemochromatosis gene (HFE) mutations in Russian healthy women and patients with estrogen-dependent cancers.
Biochim Biophys Acta
; 1762(1): 59-65, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16216474
2.
Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trial.
J Natl Cancer Inst
; 106(1): djt337, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24317176
3.
Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer.
J Clin Oncol
; 28(30): 4594-600, 2010 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20855825